Design and Evaluate 12 Week Group Therapy Intervention for HIV+ Methamphetamine Users and Deliver It Within an HIV/AIDS Primary Care Setting. - 1 - Related Studies

Design and Evaluate 12 Week Group Therapy Intervention for HIV+ Methamphetamine Users and Deliver It Within an HIV/AIDS Primary Care Setting. - 1

This study is not yet open for participant recruitment.

Study NCT00249678. Last updated on November 3, 2005. Information provided by National Institute on Drug Abuse (NIDA)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Behavior Therapy
		Methamphetamine

2	Interventions listed in this trial
		Behavior Therapy

3	Additional drug interventions recognized in this trial
		Methamphetamine

4	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Uptake Inhibitors
		Autonomic Agents
		Central Nervous System Agents
		Central Nervous System Stimulants
		Dopamine Agents
		Dopamine Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Peripheral Nervous System Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Sympathomimetics
		Therapeutic Uses

5	Sponsors listed in this trial
		National Institute on Drug Abuse (NIDA)
		University of California, Los Angeles